KindlyMD(TM) Appoints Jeremy Joyal, MD as Medical Director
KindlyMD (NASDAQ:KDLY) has appointed Dr. Jeremy Joyal as Medical Director. Dr. Joyal, a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine, will oversee the company's clinical practices and develop program protocols for pain management. His responsibilities include ensuring adherence to current standards, implementing advanced pain management programs, and collaborating with healthcare providers to ensure comprehensive patient care across KindlyMD's platform.
Dr. Joyal's expertise is expected to enhance KindlyMD's clinical operations and patient care. He graduated from Brigham Young University with a degree in Neuroscience and earned his MD from the Medical College of Wisconsin. Dr. Joyal specialized in Anesthesiology at Washington University in St. Louis and completed a Pain Medicine fellowship at the University of Utah in 2014.
KindlyMD (NASDAQ:KDLY) ha nominato il Dr. Jeremy Joyal come Direttore Medico. Il Dr. Joyal, medico autorizzato con certificazioni in Anestesiologia, Medicina del Dolore e Medicina delle Dipendenze, supervisionerà le pratiche cliniche dell'azienda e svilupperà protocolli per la gestione del dolore. Tra le sue responsabilità ci sono l'assicurazione del rispetto degli standard vigenti, l'implementazione di programmi avanzati per la gestione del dolore e la collaborazione con i fornitori di assistenza sanitaria per garantire una cura completa dei pazienti attraverso la piattaforma di KindlyMD.
Le competenze del Dr. Joyal si prevede che migliorino le operazioni cliniche e l'assistenza ai pazienti di KindlyMD. Ha conseguito la laurea in Neuroscienze presso la Brigham Young University e ha ottenuto il suo MD presso il Medical College of Wisconsin. Il Dr. Joyal si è specializzato in Anestesiologia presso la Washington University di St. Louis e ha completato una fellowship in Medicina del Dolore presso l'Università dell'Utah nel 2014.
KindlyMD (NASDAQ:KDLY) ha designado al Dr. Jeremy Joyal como Director Médico. El Dr. Joyal, un médico licenciado con certificaciones en Anestesiología, Medicina del Dolor y Medicina de Adicciones, supervisará las prácticas clínicas de la empresa y desarrollará protocolos de manejo del dolor. Sus responsabilidades incluyen garantizar el cumplimiento de los estándares actuales, implementar programas avanzados de manejo del dolor y colaborar con proveedores de atención médica para asegurar una atención integral al paciente a través de la plataforma de KindlyMD.
Se espera que la experiencia del Dr. Joyal mejore las operaciones clínicas y la atención al paciente de KindlyMD. Se graduó de Brigham Young University con un título en Neurociencia y obtuvo su MD en el Medical College of Wisconsin. El Dr. Joyal se especializó en Anestesiología en Washington University en St. Louis y completó una beca en Medicina del Dolor en la Universidad de Utah en 2014.
KindlyMD (NASDAQ:KDLY)는 드 제레미 조얄을 의료 이사로 임명했습니다. 조얄 박사는 마취학, 통증 의학 및 중독 의학 분야에서 보드 인증을 받은 면허 의사로서 회사의 클리닉 관행을 감독하고 통증 관리 프로그램 프로토콜을 개발할 것입니다. 그의 책임에는 현재 표준 준수 보장, 고급 통증 관리 프로그램 구현 및 KindlyMD의 플랫폼을 통해 포괄적인 환자 치료를 보장하기 위해 의료 제공자와 협력하는 것이 포함됩니다.
조얄 박사의 전문 지식은 KindlyMD의 임상 운영 및 환자 치료를 향상시킬 것으로 기대됩니다. 그는 브리검 영 대학교에서 신경 과학 학위를 받았고 위스콘신 의과대학에서 MD를 취득했습니다. 조얄 박사는 세인트 루이스의 워싱턴 대학교에서 마취학을 전공했고, 2014년 유타 대학교에서 통증 의학 펠로우십을 완료했습니다.
KindlyMD (NASDAQ:KDLY) a nommé le Dr. Jeremy Joyal comme Directeur Médical. Le Dr. Joyal, un médecin agréé avec des certifications en Anesthésie, Médecine de la Douleur et Médecine de la Dépendance, supervise les pratiques cliniques de l'entreprise et développe des protocoles de gestion de la douleur. Ses responsabilités incluent l'assurance de la conformité aux normes actuelles, l'implémentation de programmes avancés de gestion de la douleur et la collaboration avec les prestataires de soins de santé pour assurer des soins complets aux patients via la plateforme de KindlyMD.
On s'attend à ce que l'expertise du Dr. Joyal améliore les opérations cliniques et les soins aux patients de KindlyMD. Il est diplômé de la Brigham Young University avec un diplôme en Neurosciences et a obtenu son MD au Medical College of Wisconsin. Le Dr. Joyal s'est spécialisé en Anesthésie à la Washington University de St. Louis et a complété une bourse en Médecine de la Douleur à l'Université de l'Utah en 2014.
KindlyMD (NASDAQ:KDLY) hat Dr. Jeremy Joyal zum Medizinischen Direktor ernannt. Dr. Joyal, ein lizenzierter Arzt mit Facharztqualifikationen in Anästhesiologie, Schmerzmedizin und Suchtmedizin, wird die klinischen Praktiken des Unternehmens überwachen und Programmprotokolle für das Schmerzmanagement entwickeln. Zu seinen Aufgaben gehört es, die Einhaltung aktueller Standards sicherzustellen, fortschrittliche Schmerzmanagementprogramme umzusetzen und mit Gesundheitsdienstleistern zusammenzuarbeiten, um eine umfassende Patientenversorgung über die Plattform von KindlyMD zu gewährleisten.
Die Expertise von Dr. Joyal wird voraussichtlich die klinischen Abläufe und die Patientenversorgung von KindlyMD verbessern. Er absolvierte die Brigham Young University mit einem Abschluss in Neurowissenschaften und erwarb seinen MD am Medical College of Wisconsin. Dr. Joyal spezialisierte sich in Anästhesiologie an der Washington University in St. Louis und schloss 2014 ein Fellowship in Schmerzmedizin an der Universität von Utah ab.
- Appointment of a highly qualified Medical Director with multiple board certifications
- Potential for improved clinical practices and pain management protocols
- Enhanced collaboration with healthcare providers and specialists
- Strengthened leadership team with expertise in pain management and addiction medicine
- None.
Dr. Joyal, a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine, will oversee the Company's clinical practices and develop program protocols for pain management
SALT LAKE CITY, UT / ACCESSWIRE / August 29, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it appointed Jeremy Joyal, MD, as Medical Director, where he will oversee the Company's clinical practices while developing and implementing program protocols for pain management.
Dr. Joyal strengthens the KindlyMD leadership team by overseeing clinical practices, ensuring adherence to the Company's current standards and regulatory approach. He also assists in the development and implementation of advanced pain management programs, quality assurance, and the creation of updated policies and procedures. In addition, Dr. Joyal will play a key role in collaborating with healthcare providers and specialists to ensure comprehensive patient care is offered across the Company's platform.
Tim Pickett, PA-C, KindlyMD founder and CEO, said, "Dr. Joyal brings a wealth of expertise and a commitment to excellence that greatly enhances our clinical operations and patient care. Known for his strong connections in the interventional pain space, he is an advocate for mental health and supportive of medical cannabis treatment. We are excited to welcome Dr. Joyal and look forward to the positive impact he will have on our clinics and the patients we serve."
Dr. Joyal is a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine. Dr. Joyal graduated from Brigham Young University with a degree in Neuroscience in 2004 and earned his MD from the Medical College of Wisconsin. He specialized in Anesthesiology at Washington University in St. Louis, and further specialized in Pain Medicine through the University of Utah's fellowship program, graduating in 2014. He also offers medication-assisted treatment for opioid addiction.
Dr. Joyal commented, "I am thrilled to join the KindlyMD team and contribute to our shared mission of advancing patient care. My goal is to bring innovative pain management strategies with a compassionate approach to enhance our patients' well-being and overall quality of life, and I look forward to working with the KindlyMD leadership team to achieve this."
About KindlyMD
KindlyMDTM is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.
For more information, please visit www.kindlymd.com.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including, but not limited to, the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com
SOURCE: KindlyMD, Inc
View the original press release on accesswire.com
FAQ
Who is the new Medical Director of KindlyMD (KDLY)?
What are Dr. Jeremy Joyal's qualifications for his role at KindlyMD (KDLY)?
What will be Dr. Joyal's main responsibilities at KindlyMD (KDLY)?
How might Dr. Joyal's appointment impact KindlyMD's (KDLY) operations?
